Clinical Drug Experience Knowledgebase

bleomycin (blenoxane) (1 trial)

cyclophosphamide (cytoxan) (6 trials)

dacarbazine (dtic-dome) (1 trial)

doxorubicin (Doxil) (4 trials)

etoposide (vepesid) (1 trial)

Filgrastim (neupogen) (1 trial)

prednisone (meticorten) (5 trials)

procarbazine (matulane) (1 trial)

rituximab (rituxan) (5 trials)

sargramostim (leukine) (2 trials)

vinblastine (velban) (1 trial)

vincristine (oncovin) (5 trials)

cytarabine (cytosar-u) (1 trial)

fludarabine (fludara) (1 trial)

glofitamab (Columvi) (1 trial)

idarubicin (idamycin) (1 trial)

imatinib (gleevec) (1 trial)

Imetelstat (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

naltrexone (revia) (1 trial)

nilotinib (tasigna) (1 trial)

obinutuzumab (gazyva) (1 trial)

pirtobrutinib (Jaypirca) (1 trial)

tocilizumab (actemra) (1 trial)

aprepitant (Emend) (1 trial)

lorazepam (ativan) (1 trial)

metoclopramide (reglan) (1 trial)

prochlorperazine (compazine) (1 trial)